In the last trading session, 4.17 million shares of the Ocugen Inc (NASDAQ:OCGN) were traded, and its beta was 3.75. Most recently the company’s share price was $0.92, and it changed around $0.03 or 3.49% from the last close, which brings the market valuation of the company to $266.16M. OCGN currently trades at a discount to its 52-week high of $2.11, offering almost -129.35% off that amount. The share price’s 52-week low was $0.34, which indicates that the current value has risen by an impressive 63.04% since then. We note from Ocugen Inc’s average daily trading volume that its 10-day average is 2.9 million shares, with the 3-month average coming to 3.95 million.

Ocugen Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended OCGN as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Ocugen Inc is expected to report earnings per share of -0.05 for the current quarter.

Ocugen Inc (NASDAQ:OCGN) trade information

Instantly OCGN has showed a green trend with a performance of 3.49% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.9899 on recent trading dayincreased the stock’s daily price by 7.06%. The company’s shares are currently up 60.80% year-to-date, but still down -1.64% over the last five days. On the other hand, Ocugen Inc (NASDAQ:OCGN) is -6.17% down in the 30-day period. We can see from the shorts that 51.92 million shares have been sold at a short interest cover period of 14.1 day(s).

The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 81.6% from its current value. Analyst projections state that OCGN is forecast to be at a low of $3.5 and a high of $6.

Ocugen Inc (OCGN) estimates and forecasts

Ocugen Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -27.77 percent over the past six months and at a 23.08% annual growth rate that is well above the industry average of 17.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 16.70% in revenue this quarter, and will report a decrease of -100.00% in the next quarter. The year-over-year growth rate is expected to be -54.40%, down from the previous year.

Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 300k in revenue for the current quarter. 3 analysts expect Ocugen Inc to make 400k in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at -93.40%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 41.20%.

OCGN Dividends

Ocugen Inc’s next quarterly earnings report is expected to be released in November.

Ocugen Inc (NASDAQ:OCGN)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 1.41% of Ocugen Inc shares, and 23.94% of them are in the hands of institutional investors. The stock currently has a share float of 24.28%. Ocugen Inc stock is held by 123.0 institutions, with BLACKROCK INC. being the largest institutional investor. By 2024-06-30, it held 6.9665% of the shares, which is about 17.92 million shares worth $27.78 million.

VANGUARD GROUP INC, with 6.0339% or 15.52 million shares worth $24.06 million as of 2024-06-30, holds the second largest percentage of outstanding shares.